Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

49.91USD
17 Jan 2018
Change (% chg)

$2.31 (+4.85%)
Prev Close
$47.60
Open
$48.07
Day's High
$50.25
Day's Low
$48.00
Volume
51,955
Avg. Vol
54,281
52-wk High
$50.25
52-wk Low
$20.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.74 December 18 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.75 1.10 0.40 --
Quarter Ending Jun-18 2 0.75 1.10 0.40 --
Year Ending Dec-18 6 2.04 4.24 0.80 2.34
Earnings (per share)
Quarter Ending Mar-18 3 -0.74 -0.62 -0.89 --
Quarter Ending Jun-18 3 -0.77 -0.62 -0.91 --
Year Ending Dec-18 6 -3.12 -2.48 -3.53 -2.41

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.62 0.43 0.18 29.48
Quarter Ending Jun-17 0.78 0.44 0.34 43.19
Quarter Ending Mar-17 0.82 0.35 0.46 56.67
Quarter Ending Dec-16 0.99 1.04 0.05 5.40
Quarter Ending Sep-16 0.66 1.23 0.57 86.80

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 0.75 0.75 0.75 0.75 --
Quarter Ending Jun-18 0.75 0.75 0.75 0.75 --
Year Ending Dec-18 2.04 2.04 2.04 2.57 2.34

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 1 0 1
Earnings